Investor Relations

A leadership story in the field of advanced cell therapy

Investor Relations

SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
Feb 13, 2018
Document Date
Dec 31, 2017
Form Description
Annual filing director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Vericel Corporation
Issuer
AASTROM BIOSCIENCES INC
Filer
Colangelo Dominick

Day High:
Day Low:
Volume:
on
Copyright West LLC. Minimum 15 minutes delayed.